Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
Pollock C, Stefánsson B, Reyner D, et al.
The Lancet Diabetes & Endocrinology. Pub. online 13 April 2019
Leggi